Analysts set USD 41.60 consensus for The Pennant Group stock
Published on 10/20/2026 at 21:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst consensus and dates
- Eight analysts held a Moderate Buy consensus at USD 41.60 on October 8, 2026.
- Second-quarter revenue reached USD 297.98 million in 2026.
- The Pennant Group stock costs EUR 37.10 at Lang & Schwarz on October 20, 2026 at 9:31 p.m. CEST.
- The next estimated earnings date is November 4, 2026.
The Pennant Group (ISIN US70805E1091) had a Moderate Buy consensus from eight analysts with an average target of USD 41.60 on October 8, 2026, according to MarketBeat. The Pennant Group was trading at EUR 37.10 at Lang & Schwarz on October 20, 2026 at 9:31 p.m. CEST.
Revenue advanced in the second quarter
The company reported revenue of USD 297.98 million for the second quarter of 2026, compared with USD 285.36 million in the first quarter. That was a 4.42 percent sequential increase, based on the quarterly statement compiled by Business Quant. Operating income was USD 17.19 million in the second quarter, versus USD 17.30 million in the first quarter.
Stock stays near its yearly high
On Nasdaq, The Pennant Group was trading at USD 41.74 on October 20, 2026 at 3:34 p.m. ET, up 2.66 percent from USD 40.66. The 52-week range was USD 22.25 to USD 42.74, placing the stock 2.34 percent below its high. Volume stood at 150,325 shares at that timestamp.
Valuation and the next reporting date
The shares carried a trailing price-to-earnings ratio of 46.32 and a market capitalization of USD 1.5 billion on October 20, 2026. The company said through its investor-relations page that it operates more than 120 home health and hospice agencies and more than 50 senior living communities.
The Pennant Group is estimated to report third-quarter 2026 results on November 4, 2026 after the market closes, with a conference call scheduled for November 5, according to MarketBeat. The published estimate calls for USD 299.34 million in revenue and earnings per share of USD 0.36.
What the valuation leaves investors watching
The next report will put the recent revenue increase against the 46.32 earnings multiple and the USD 42.74 yearly high. The USD 41.60 consensus target is slightly below the latest Nasdaq price, while the higher individual target of USD 48.00 from Truist remains part of the analyst range reported by MarketBeat on October 8.
Price and reporting date
The euro quotation stood at EUR 37.10 at Lang & Schwarz on October 20, 2026 at 9:31 p.m. CEST. The next scheduled earnings date is November 4, 2026. The further course of trading is shown by the continuously updated real-time quote of The Pennant Group stock.
The Pennant Group market facts
- Company: The Pennant Group, Inc.
- ISIN: US70805E1091
- Ticker: PNTG
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 20, 2026, 9:31 p.m. CEST): EUR 37.10
- Market capitalization: USD 1.5 billion (as of October 20, 2026)
- 52-week range: USD 22.25-42.74 (as of October 20, 2026)
- Sector / Industry: Healthcare / Medical Care Facilities
- Next earnings date: November 4, 2026
Market context: Market report Nasdaq Composite.
